Blood Test Could Indicate Which Patients Will Respond to Immunotherapy – Scicasts (press release) (blog)
Scicasts (press release) (blog) |
Blood Test Could Indicate Which Patients Will Respond to Immunotherapy
Scicasts (press release) (blog) London, UK (Scicasts) — A test that measures the levels of two types of immune cell in the blood could identify which cancer patients are most likely to respond to immunotherapy. The test gives a measure of a patient’s immune system health by … |
fox6now.com |
‘There is promise:’ Groundbreaking cancer treatment gives hope to terminal patients
fox6now.com Years of chemotherapy, stem cell transplants and treatments passed before Carroll was presented with chimeric antigen receptor T (CAR–T) cell therapy. It was developed in the last five years. Doctors take a patient’s T cells and re-engineer them. “In … Wisconsin cancer patient becomes first in world to undergo breakthrough treatmentWTMJ-TV (press release) (blog) |
EurekAlert (press release) |
Simmons Cancer Center researchers part of historic CAR–T breakthrough
EurekAlert (press release) 1, 2018 – A historic study involving researchers from UT Southwestern’s Harold C. Simmons Comprehensive Cancer Center demonstrates the effectiveness of CAR–T therapy, which uses genetically modified immune cells to treat acute lymphoblastic leukemia … |